CC
COLL icon

Clearline Capital’s Collegium Pharmaceutical COLL Stock Holding History

Clearline Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-101,498
Closed -$2.27M – 108
2023
Q3 		$2.27M Buy
101,498
+8,754
+9% +$200K 0.19% 82
2023
Q2 		$1.99M Buy
+92,744
New +$2.11M 0.12% 75
2022
Q4 		– Sell
-153,094
Closed -$2.45M – 128
2022
Q3 		$2.45M Hold
153,094
– – 0.29% 66
2022
Q2 		$2.71M Buy
+153,094
New +$2.58M 0.35% 61
2020
Q3 		– Sell
-44,698
Closed -$782K – 85
2020
Q2 		$782K Buy
+44,698
New +$875K 0.25% 50

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clearline Capital's COLL Position: Q4 2023 in Review

Clearline Capital sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 101,498 shares — an estimated $2.27M sold.

Clearline Capital first reported a position in COLL in Q2 2020 and held it in 5 quarters. The position peaked at $2.71M in Q2 2022. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

  • Clearline Capital reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Clearline Capital sold 101,498 Collegium Pharmaceutical shares in Q4 2023, an estimated $2.27M.
  • Clearline Capital first reported a position in Collegium Pharmaceutical in Q2 2020 and held it in 5 quarters.
  • Clearline Capital's Collegium Pharmaceutical position peaked at $2.71M in Q2 2022.
  • 193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Clearline Capital's 13F filing for Q4 2023, filed 14 Feb 2024.